Millan, Febriel Jane B.
HRN: 15-98-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/01/2025
CEFUROXIME 500MG (TAB)
12/01/2025
12/08/2025
PO
500 MG
BID
2ND DEGREE RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes